Dr. James Clarke, chief of diagnostic imaging, Nova Scotia Health
“Today marks a very exciting day for patients in Nova Scotia who will benefit from the QEII having world-leading nuclear medicine technology available. The QEII Foundation is proud to be part of this project, working with generous donors to raise $3 million to fund two new scanners. This will be a game-changer for patients living with diseases like cancer and cardiac disease, and it is a prime example of the impact philanthropy has on transforming care through the QEII. We look forward to continued work with our donor community to raise funds to support this incredible project.”
Susan Mullin, president and CEO, QEII Foundation
“Advancing Nuclear Medicine capabilities in Atlantic Canada is important as we face an aging population that may experience an increasing prevalence of cancer. The QEII Health Sciences Centre in Halifax has been a long-standing collaborator with GE HealthCare particularly in Molecular Imaging and PET/CT, and we are excited to open the next chapter in our relationship with the first StarGuide SPECT/CT deployed in Canada. We wish the QEII Foundation continued success with its campaign to support another StarGuide system at QEII Health Sciences Centre as they build out capabilities for their Theranostics program.”
Mike Hamilton, president of GE HealthCare, Canada
Back to HCB News
